The Hidden Costs of Generic Specialty Drugs: FTC Exposes $7.3 Billion Markup by Top PBMs
Pharmacy benefit managers (PBMs) are under intense scrutiny following a Federal Trade Commission (FTC) report exposing $7.3 billion in markups on specialty generic drugs over a six-year period. CVS Caremark, OptumRx, and Express Scripts, subsidiaries of CVS Health, UnitedHealth Group, and Cigna, respectively, have been accused of inflating prices for critical medications treating conditions like […]
The Hidden Costs of Generic Specialty Drugs: FTC Exposes $7.3 Billion Markup by Top PBMs Read More »